Book contents
- Endocrine Pathology
- Endocrine Pathology
- Copyright page
- Contents
- Acknowledgements
- Contributors
- Preface
- Section I Clinical approaches
- Section II Investigative techniques
- Chapter 4 Biochemical testing
- Chapter 5 Radiological imaging
- Chapter 6 Cytological assessment
- Chapter 7 Intraoperative consultations
- Chapter 8 Morphology and immunohistochemistry
- Chapter 9 Cytogenetic and molecular genetic testing
- Chapter 10 Experimental models of endocrine diseases
- Section III Anatomical endocrine pathology
- Index
- References
Chapter 8 - Morphology and immunohistochemistry
from Section II - Investigative techniques
Published online by Cambridge University Press: 13 April 2017
Book contents
- Endocrine Pathology
- Endocrine Pathology
- Copyright page
- Contents
- Acknowledgements
- Contributors
- Preface
- Section I Clinical approaches
- Section II Investigative techniques
- Chapter 4 Biochemical testing
- Chapter 5 Radiological imaging
- Chapter 6 Cytological assessment
- Chapter 7 Intraoperative consultations
- Chapter 8 Morphology and immunohistochemistry
- Chapter 9 Cytogenetic and molecular genetic testing
- Chapter 10 Experimental models of endocrine diseases
- Section III Anatomical endocrine pathology
- Index
- References
- Type
- Chapter
- Information
- Endocrine Pathology , pp. 250 - 260Publisher: Cambridge University PressPrint publication year: 2000
References
DeLellis, RA, Lloyd, RV, Heitz, PU, Eng, C, eds. World Health Organization Classification of Tumours of Endocrine Organs. Lyon: International Agency for Research on Cancer, 2004.Google Scholar
Lloyd, RV. Adrenal cortical tumors, pheochromocytomas and paragangliomas. Mod Pathol 2011;24(suppl 2):S58–S65.CrossRefGoogle ScholarPubMed
Bosman, F, Carneiro, F, Hruban, RH, Theise, ND, eds. WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer, 2010.Google Scholar
Kontogeorgos, G. Classification and pathology of pituitary tumors. Endocrine 2005;28:27–35.CrossRefGoogle ScholarPubMed
Al-Shraim, M, Asa, SL. The 2004 World Health Organization classification of pituitary tumors: what is new? Acta NeuroPathol 2006;111:1–7.CrossRefGoogle Scholar
Saeger, W, Lüdecke, DK, Buchfelder, M, Fahlbusch, R, Quabbe, HJ, Petersenn, S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 2007;156:203–216.CrossRefGoogle ScholarPubMed
Medeiros, LJ, Weiss, LM. New developments in the pathologic diagnosis of adrenal cortical neoplasms. A review. Am J Clin Pathol 1992;97:73–83.CrossRefGoogle ScholarPubMed
Fuhrman, SA, Lasky, LC, Limas, C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655–663.CrossRefGoogle ScholarPubMed
LiVolsi, VA. Papillary thyroid carcinoma: an update. Mod Pathol 2011;24(suppl 2:S1–S9.Google Scholar
Dabbs, D. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, 4th edn. Philadelphia, PA: Elsevier, 2013.Google Scholar
Shi, SR, Shi, Y, Taylor, CR. Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades. J Histochem CytoChem 2011;59:13–32.Google Scholar
Sino Biological. Immunohistochemical Methods. Beijing: Sino Biological, 2015 (http://www.immunohistochemistry.us/what-is-immunohistochemistry/immunohistochemical-methods.html, accessed 27 July 2015).Google Scholar
Werling, RW, Yaziji, H, Bacchi, CE, Gown, AM CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol 2003;27:303–310.CrossRefGoogle ScholarPubMed
Kaimaktchiev, V, Terracciano, L, Tornillo, L, Spichtin, H, Stoios, D, Bundi, M, Korcheva, V, Mirlacher, M, Loda, M, Sauter, G, Corless, CL. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol 2004;17:1392–1399.Google Scholar
Gill, AJ, Benn, DE, Chou, A, Clarkson, A, Muljono, A, Meyer-Rochow, GY, Richardson, AL, Sidhu, SB, Robinson, BG, Clifton-Bligh, RJ. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes. Hum Pathol 2010;41:805–814.Google Scholar
Volante, M, Brizzi, MP, Faggiano, A, La Rosa, S, Rapa, I, Ferrero, A, Mansueto, G, Righi, L, Garancini, S, Capella, C, De Rosa, G, Dogliotti, L, Colao, A, Papotti, M. Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy. Mod Pathol 2007;20:1172–1182.Google Scholar
Koperek, O, Kornauth, C, Capper, D, Berghoff, AS, Asari, R, Niederle, B, von Deimling, A, Birner, P, Preusser, M. Immunohistochemical detection of the BRAFV600E-mutated protein in papillary thyroid carcinoma Am J Surg Pathol 2012;36:844–850.Google Scholar
Salehi, F, Scheithauer, BW, Kros, JM, Lau, Q, Fealey, M, Erickson, D, Kovacs, K, Horvath, E, Lloyd, RV. MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas. J Neurooncol 2011;104:647–657.CrossRefGoogle ScholarPubMed
Widhalm, G, Wolfsberger, S, Preusser, M, Woehrer, A, Kotter, MR, Czech, T, Marosi, C, Knosp, E. O-Methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment? Cancer 2009;115:1070–1080.CrossRefGoogle Scholar